MedTrace Logo

AVS After 1mg DST to Determine Subtype in PA

NCT04709185 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2023-06-01

No results posted yet for this study

Summary

To compare the effect of different procedures of AVS(after 1mg DST or not) in determining the subtypes and long-term outcomes of PA

Conditions

  • Primary Aldosteronism

Interventions

DRUG

Dexamethasone 1 MG Oral Tablet

oral 1 mg dexamethasone at 23:00-24:00 the night before AVS

DRUG

Placebo

oral placebo at 23:00-24:00 the night before AVS

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Xiaomu Li, PhD · Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-08
Primary Completion
2022-10-30
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04709185 on ClinicalTrials.gov